Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera ® ) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial
- Resource Type
- Source
- Hematological Oncology. 40:930-940
- Subject
Cancer Research Oncology Hematology General Medicine - Language
- ISSN
- 1099-1069
0278-0232